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Background
The goal of this study was to design structural mimics of
HIV-1 epitopes that have the potential to induce broadly
neutralizing antibodies (bnAbs). The structure of the gp41
membrane proximal external region (MPER), targeted by
three bnAbs, requires further definition. Experiments were
designed to select epitopes with enhanced binding to
MPER bnAbs, to identify neutralization-competent MPER
structures, and to determine if selected MPER epitopes
can broaden the immune response as potential vaccines.
Methods
MPER epitopes were selected by biopanning with phage-
displayed peptide libraries against bnAbs 4E10, 2F5 and
Z13. Epitopes were screened in competition binding assays
where M13-displayed epitopes competed with envelope
peptides or infectious HIV-1 for antibody binding. In vivo
response to MPER was assessed by M13 immunoprecipi-
tation and neutralization competition assays using HIV-
positive plasma, and immunogenicity of select epitopes
was assessed in BALB/c mice.
Results
Forty-six unique 4E10 epitopes were identified, repre-
senting both MPER homologous and non-homologous
sequences. Fourteen epitopes, capable of competing with
MPER peptide and HIV-1 for 4E10 binding, bound
HIV-positive IgG. Of these, five epitopes absorbed
MPER-specific neutralizing activity in HIV-positive
patient plasma. Mouse immunization with the selected
neutralization-competent MPER epitopes elicited HIV-1
specific cellular and humoral immune responses and
boosted the neutralizing activity of a gp145 Env subunit
vaccine.
Conclusion
This study demonstrates the diversity of epitope recogni-
tion by 4E10 and the unique response to MPER in vivo.
The M13-displayed, neutralization-competent structures
of the 4E10 epitopes have the potential to elicit and boost
HIV-1 neutralizing antibody production in mice. Phage-
displayed epitopes can rapidly and inexpensively be
selected to provide epitope-specific depth and variation to
HIV-1 vaccine designs without requiring modification to
major vaccine components.
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